Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Regnery

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Cancers|July 24, 2021
Neurocognitive Outcomes in Pediatric Patients Following Brain IrradiationKatharina Weusthof, Peggy Lüttich, Sebastian Regnery, et al.
Journal of Neuro-Oncology|June 11, 2026
Long-term outcomes of adjuvant proton radiotherapy (PRT) for residual pituitary adenoma (PA) in adults - a retrospective, single institute experienceFabian J K Allmendinger, Maximilian Deng, Sebastian Regnery, et al.
Cancers|June 22, 2023
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Philipp Hoegen, Sebastian Regnery, et al.
Journal of Neuro-Oncology|January 4, 2023
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3Tanja Eichkorn, Jonathan W Lischalk, Juliane Hörner-Rieber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomesSebastian Regnery, Carolin Buchele, Lars Piskorski, et al.
Frontiers in Oncology|January 28, 2022
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk LocationsSebastian Regnery, Carolin Buchele, Fabian Weykamp, et al.
Neuroimage. Clinical|October 1, 2020
Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patientsSebastian Regnery, Nicolas G R Behl, Tanja Platt, et al.
Radiology|February 19, 2020
Quantitative Dynamic Oxygen 17 MRI at 7.0 T for the Cerebral Oxygen Metabolism in GliomaDaniel Paech, Armin M Nagel, Miriam N Schultheiss, et al.
Cancers|December 23, 2022
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, et al.
Radiation Oncology (London, England)|May 29, 2023
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapySebastian Regnery, Lukas Leiner, Carolin Buchele, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Cancers|July 24, 2021
Neurocognitive Outcomes in Pediatric Patients Following Brain IrradiationKatharina Weusthof, Peggy Lüttich, Sebastian Regnery, et al.
Journal of Neuro-Oncology|June 11, 2026
Long-term outcomes of adjuvant proton radiotherapy (PRT) for residual pituitary adenoma (PA) in adults - a retrospective, single institute experienceFabian J K Allmendinger, Maximilian Deng, Sebastian Regnery, et al.
Cancers|June 22, 2023
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Philipp Hoegen, Sebastian Regnery, et al.
Journal of Neuro-Oncology|January 4, 2023
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3Tanja Eichkorn, Jonathan W Lischalk, Juliane Hörner-Rieber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomesSebastian Regnery, Carolin Buchele, Lars Piskorski, et al.
Frontiers in Oncology|January 28, 2022
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk LocationsSebastian Regnery, Carolin Buchele, Fabian Weykamp, et al.
Neuroimage. Clinical|October 1, 2020
Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patientsSebastian Regnery, Nicolas G R Behl, Tanja Platt, et al.
Radiology|February 19, 2020
Quantitative Dynamic Oxygen 17 MRI at 7.0 T for the Cerebral Oxygen Metabolism in GliomaDaniel Paech, Armin M Nagel, Miriam N Schultheiss, et al.
Cancers|December 23, 2022
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, et al.
Radiation Oncology (London, England)|May 29, 2023
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapySebastian Regnery, Lukas Leiner, Carolin Buchele, et al.
Pageof 8